Cargando…

Clofilium inhibits Slick and Slack potassium channels

Slick and Slack high-conductance potassium channels have been recently discovered, and are found in the central nervous system and in the heart. Both channels are activated by Na(+) and Cl(−), and Slick channels are also inhibited by adenosine triphospate (ATP). An important role of setting the rest...

Descripción completa

Detalles Bibliográficos
Autores principales: de los Angeles Tejada, Maria, Stolpe, Kathleen, Meinild, Anne-Kristine, Klaerke, Dan A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526865/
https://www.ncbi.nlm.nih.gov/pubmed/23271893
http://dx.doi.org/10.2147/BTT.S33827
_version_ 1782253632259883008
author de los Angeles Tejada, Maria
Stolpe, Kathleen
Meinild, Anne-Kristine
Klaerke, Dan A
author_facet de los Angeles Tejada, Maria
Stolpe, Kathleen
Meinild, Anne-Kristine
Klaerke, Dan A
author_sort de los Angeles Tejada, Maria
collection PubMed
description Slick and Slack high-conductance potassium channels have been recently discovered, and are found in the central nervous system and in the heart. Both channels are activated by Na(+) and Cl(−), and Slick channels are also inhibited by adenosine triphospate (ATP). An important role of setting the resting membrane potential and controlling the basal excitability of neurons has been suggested for these channels. In addition, no specific blockers for these channels are known up to the present. With the purpose of studying the pharmacological characteristics of Slick and Slack channels, the effects of exposure to the antiarrhythmic compound clofilium were evaluated. Clofilium was able to modulate the activity of Slick and Slack channels effectively, with a stronger effect on Slack than Slick channels. In order to evaluate the pharmacological behavior of Slick and Slack channels further, 38 commonly used potassium channel blockers were tested. Screening of these compounds did not reveal any modulators of Slick and Slack channels, except for clofilium. The present study provides a first approach towards elucidating the pharmacological characteristics of Slick and Slack channels and could be the basis for future studies aimed at developing potent and specific blockers and activators for these channels.
format Online
Article
Text
id pubmed-3526865
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-35268652012-12-27 Clofilium inhibits Slick and Slack potassium channels de los Angeles Tejada, Maria Stolpe, Kathleen Meinild, Anne-Kristine Klaerke, Dan A Biologics Original Research Slick and Slack high-conductance potassium channels have been recently discovered, and are found in the central nervous system and in the heart. Both channels are activated by Na(+) and Cl(−), and Slick channels are also inhibited by adenosine triphospate (ATP). An important role of setting the resting membrane potential and controlling the basal excitability of neurons has been suggested for these channels. In addition, no specific blockers for these channels are known up to the present. With the purpose of studying the pharmacological characteristics of Slick and Slack channels, the effects of exposure to the antiarrhythmic compound clofilium were evaluated. Clofilium was able to modulate the activity of Slick and Slack channels effectively, with a stronger effect on Slack than Slick channels. In order to evaluate the pharmacological behavior of Slick and Slack channels further, 38 commonly used potassium channel blockers were tested. Screening of these compounds did not reveal any modulators of Slick and Slack channels, except for clofilium. The present study provides a first approach towards elucidating the pharmacological characteristics of Slick and Slack channels and could be the basis for future studies aimed at developing potent and specific blockers and activators for these channels. Dove Medical Press 2012 2012-12-12 /pmc/articles/PMC3526865/ /pubmed/23271893 http://dx.doi.org/10.2147/BTT.S33827 Text en © 2012 Tejada et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Original Research
de los Angeles Tejada, Maria
Stolpe, Kathleen
Meinild, Anne-Kristine
Klaerke, Dan A
Clofilium inhibits Slick and Slack potassium channels
title Clofilium inhibits Slick and Slack potassium channels
title_full Clofilium inhibits Slick and Slack potassium channels
title_fullStr Clofilium inhibits Slick and Slack potassium channels
title_full_unstemmed Clofilium inhibits Slick and Slack potassium channels
title_short Clofilium inhibits Slick and Slack potassium channels
title_sort clofilium inhibits slick and slack potassium channels
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526865/
https://www.ncbi.nlm.nih.gov/pubmed/23271893
http://dx.doi.org/10.2147/BTT.S33827
work_keys_str_mv AT delosangelestejadamaria clofiliuminhibitsslickandslackpotassiumchannels
AT stolpekathleen clofiliuminhibitsslickandslackpotassiumchannels
AT meinildannekristine clofiliuminhibitsslickandslackpotassiumchannels
AT klaerkedana clofiliuminhibitsslickandslackpotassiumchannels